Nephrotoxicity Assay related Services

Creative Biolabs is a professional contract research organization (CRO) that conducts extensive research to gather specific details on renal toxicity mechanisms to deliver cutting-edge assays for drug discovery and research.

Necessity of Nephrotoxicity Assessment

Nephrotoxicity, also known as renal toxicity, is a prevalent cause of drug failure in the process of new drug development. The FDA recommends conducting in vitro nephrotoxicity assays on new drugs and biologics prior to testing them in vivo using animal models. Additional regulatory guidance from the FDA and EMA suggests in vitro nephrotoxicity models can detect early markers of nephrotoxicity more accurately.

To meet the increasing demands of nephrotoxicity evaluation, Creative Biolabs builds a team of experienced experts who can assist our clients with research design, experimental execution, and data analysis during the early stages of drug discovery. To reduce expenses and shorten research timeframes associated with novel drug development, we offer the following services for assessing nephrotoxicity:

You are able to easily reach a Creative Biolabs expert or our Customer Service team. Contact us with questions or to discuss your specific discovery challenges.